UnitedHealth cites near-term pressures in ACA, Medicare cuts The near-term pressures are expected to cost over $1.50 per share in 2014. The company has set a target of having more than $65B in value based contracts with care providers by 2018. It says it will closely study the development of individual public exchanges in 2014 and be "selective" in its approaches for 2015. Initial Medicare growth is within the company's estimates and continue to expect commercial group risk membership to be stable in 2014 with commercial individual insured membership declining over the course of the year. Optum expects strong top and bottom line growth in 2014 with a range of $45B-$46B in revenue. Optum's earnings are expected to be strong in 2H14 due to growth investments early in the year. Expects cash flow from operations in range of $7.8B-$8.2B in 2014 and expect to return $4B to shareholders through repurchase and dividend. Comments taken from Q4 earnings conference call.
UnitedHealth unit receives patent for hearing test kit hi HealthInnovations, an Optum business and UnitedHealth Group company, has received a 2015 U.S. Patent for an air conduction hearing test kit used by primary care physicians and other health professionals. The hearing test kit is an affordable and easy-to-use resource to test for hearing loss, a condition that affects more than 48 million people nationwide.